Treatment after failure of frontline therapy of chronic myeloid leukemia in chronic phase including allogeneic hematopoietic stem cell transplantation

The treatment outcomes of chronic myeloid leukemia in chronic phase (CML-CP) have dramatically improved with comparable life-expectancy to average of general population in tyrosine kinase inhibitor (TKI) era. However, less than a half of patients who started with TKI can remain on frontline TKI. The...

Descripción completa

Detalles Bibliográficos
Autor principal: Uhm, Jieun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133855/
https://www.ncbi.nlm.nih.gov/pubmed/37105565
http://dx.doi.org/10.5045/br.2023.2023054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133855/
https://www.ncbi.nlm.nih.gov/pubmed/37105565
http://dx.doi.org/10.5045/br.2023.2023054

Ejemplares similares